This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

An Autism Study Using Nambudripad's Food Allergy Elimination Treatments

This study has been completed.
Information provided by:
Nambudripad's Allergy Research Foundation Identifier:
First received: October 31, 2005
Last updated: June 25, 2008
Last verified: April 2006
1. We hypothesize that children in the experimental group will show a significant improvement over the control group as all food allergens groups and some other relevant allergenic substances are desensitized in a systematic way using the NAET® methodology within the specified period of study.

Condition Intervention Phase
Autism Food Allergies Procedure: Acupressure treatments and NAET treatments Phase 1 Phase 2

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: An Investigation Into the Effectiveness of NAET on Autism Spectrum Disorders

Resource links provided by NLM:

Further study details as provided by Nambudripad's Allergy Research Foundation:

Primary Outcome Measures:
  • Improvement in speech and communication

Secondary Outcome Measures:
  • Elimination or reduction of commonly seen autistic traits

Estimated Enrollment: 60
Study Start Date: November 2004
Estimated Study Completion Date: November 2005
  Show Detailed Description


Ages Eligible for Study:   3 Years to 10 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

Volunteers will be selected based on the well-defined inclusion criteria such as all control and sample children showed typical autistic symptoms before NAET® treatment: made no eye contact, unable to talk and communicate. All subjects (both control and sample) should be within the age limit of 3 to10 years and should have established and demonstrated autism spectrum disorder by a conventional physician. -

Exclusion Criteria:

Any child that has a history of various complications of illness other than autism spectrum disorder would be disqualified. Previously treated with NAET treatments for this condition will be disqualified to enroll in the study. Any patient who has any of the following incidents will also be disqualified.

  1. Previous surgeries, congenital deformities of heart, lung, liver, brain, kidney, etc.
  2. Any type of cancer
  3. Aids
  4. Any physically debilitating disorders and diagnosed mental retardation, Down's syndrome, etc.
  5. Children with the history of severe allergies or anaphylactic reactions will be rejected.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00247156

United States, California
PNIB Research Center
Buena Park, California, United States, 90621
Sponsors and Collaborators
Nambudripad's Allergy Research Foundation
Principal Investigator: Devi S. Nambudripad, LAc, PhD The journal of NAET Energetics and Complementary Medicine
  More Information

Additional Information: Identifier: NCT00247156     History of Changes
Other Study ID Numbers: narfoundationautismstudy
narffoundation 101
Study First Received: October 31, 2005
Last Updated: June 25, 2008

Keywords provided by Nambudripad's Allergy Research Foundation:
eye contact

Additional relevant MeSH terms:
Autistic Disorder
Food Hypersensitivity
Child Development Disorders, Pervasive
Neurodevelopmental Disorders
Mental Disorders
Immune System Diseases
Hypersensitivity, Immediate processed this record on June 23, 2017